International Journal of General Medicine (Aug 2022)

Prevalence of Hyperuricemia and Associated Factors Among Type 2 Diabetic Patients in Jordan

  • Abujbara M,
  • Al Hourani HM,
  • Al-Raoush RI,
  • Khader YS,
  • Ajlouni K

Journal volume & issue
Vol. Volume 15
pp. 6611 – 6619

Abstract

Read online

Mousa Abujbara,1 Huda M Al Hourani,2 Reem Ibrahim Al-Raoush,1 Yousef S Khader,3 Kamel Ajlouni1 1The National Centre (Institute) for Diabetes, Endocrinology and Genetics, The University of Jordan, Amman, Jordan; 2Department of Clinical Nutrition and Dietetics, Faculty of Applied Health Sciences, The Hashemite University, Zarqa, Jordan; 3Jordan University of Science and Technology (JUST), Irbid, JordanCorrespondence: Kamel Ajlouni, The National Centre (Institute) for Diabetes, Endocrinology and Genetics, The University of Jordan, P.O. Box 13165, Amman, 11942, Jordan, Tel +962 6 534 7810, Fax +962 6 535 6670, Email [email protected]: Previous studies showed variable estimate of the prevalence of hyperuricemia in patients with type 2 diabetes mellitus (T2DM). The prevalence of hyperuricemia and associated risk factors in Jordanian patients with T2DM is largely unknown. Therefore, this study aimed to determine the prevalence of hyperuricemia and its associated factors in Jordanian patients with T2DM.Methods: A cross-sectional study was conducted on 655 patients with T2DM. A structured questionnaire was used to collect socio-demographic data. In addition, records of the study subjects were reviewed to obtain other clinical data. Weight, height, and waist circumference were measured, and body mass index was calculated. Lipid profile, serum uric acid and glycated haemoglobin were analysed. The study was conducted in accordance with the Declaration of Helsinki. An informed written consent was obtained from each participant. The confidentiality of the information was assured and only used for scientific purposes.Results: Overall, the prevalence of hyperuricemia was 28.1%. Female gender (OR: 2.37; 95%, CI: 1.63– 3.45), intake of angiotensin-converting enzyme (ACE) and angiotensin-II receptor blockers (ARBs) (OR: 1.68; 95%, CI: 1.12– 2.50), intake of β-blockers (OR: 2.20; 95%, CI: 1.51– 3.22), increased waist circumference (OR: 3.17; 95%, CI: 1.39– 7.22) and family history of hyperuricemia (OR: 2.56; 95%, CI: 1.57– 4.16) were associated with increased odds of hyperuricemia.Conclusion: Hyperuricemia was high among type 2 diabetic patients, and screening test will be useful for those patients.Keywords: uric acid, hyperuricemia, diabetes mellitus

Keywords